A Study of KF-0210 in Advanced Solid Tumors Patients
Clinical trial NCT04713891 · COMPLETED
Trial details
- NCT number
- NCT04713891
- Sponsor
- Keythera Pharmaceuticals (Australia) Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-09
- Primary completion
- 2022-12-08
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.